result handili lead valuat note remain bullish
morn report fiscal result easili beat target top-
bottom line manag issu fiscal guidanc view conserv
top-lin typic approach compel margin ep
perspect momentum use impella treat patient remain strong
new product geographi anticip continu buoy top-lin result
result despit hefti valuat remain bullish compani continu
encourag investor name
report fiscal revenu growth beat
estim despit face tough comp us impella sale strong
growth actual acceler two-year stack basi compar
last two quarter appear tct call action impact shock
revenu grew anoth tough comp oper margin came
beat target bp bottom line ep beat target
though lower tax rate lift ep
revenu guidanc call sale growth view
outlook robust potenti conserv especi low end given
nation csi program new indic rp japan launch ebit outlook
quit good well ahead model
midpoint rang manag expect tax rate rang
bp model midpoint rang
point call lot like call view
impella perform particularli impress stack two-year growth acceler
fourth quarter compar past two quarter impact tct call
action nation csi initi rp launch product grew
meaning impact anticip new indic provid
tailwind come quarter secondli found japanes revenu result
fiscal encourag manag guid japan
year go slow believ countri eventu could add hundr
million dollar sale top-lin third final manag guidanc
oper margin quit impress despit top-lin growth believ
metric move consider higher go forward hundr bp higher
stock follow page
develop manufactur circulatori support devic
intra-day price
sale
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
stock sure go receiv critic view stock given
valuat reach rarefi air right mani thing like
stori modest penetr rate new indic new geographi new product oper
leverag choos maintain bullish stanc compani consequ continu
encourag investor monopoli provid best growth med
tech suggest new money look start posit opportunist
maintain ow-rat increas pt increas price target
base sale assum net cash share
outstand previou sale estim
sourc compani report piper jaffray co estim
page
good gener incom expens net incom net incom analysi gross gener analysisu impella impella
thousand except per share data
good sold
good sold
percent sale
good sold
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
